The Food and Drug Law Institute. Food and Drug Law Journal. Copyright 1997. 52 Food Drug L.J. 429.
Coghlan, Andy So far, so good... New Scientist 8 August 1998 Vol. 159 No. 2146 http://www.islet.org/40.htm
Golberg, Jeff and Aguilera ? Hellweg, Max. "Fetal Brain ? Therapeutic Use : Parkinsonism ? treatment. " Discover jul 95, vol 16 Issue 7, pg 87, 8p, 6c
Heneine, Walid at al. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts http://www.islet.org/41.htm#XenoRisk
Williams, Rebecca D. Organ Transplants from Animals: Examining the Possibilities http://www.fda.gov/fdac/features/596_xeno.html
Aebischer P et al. transplantation of neural tissue in polymer capsules. Brain Res 1988; 448: 364
Bjorklund A, Stenevi U. Reconstruction of the Nigrostriatal dopamine pathway by Intracerebral nigral transplants. Brain Res. 1979; 177: 555-560
Boyer K, Bakay R. The History, Theory, and Present Status of Brain Transplantation. Functional Neurosurgery 1995; 6: 113-125
Deacon et al. Histological Evidence of Fetal Pig Neural Cell Survival after Transplantation into a Patient with Parkinson’s Disease. Nature Medicine 1997; 3: 350-353
Dunn EH. Primary and secondary findings in a series of attempts to transplant cerebral cortex in albino rat. J Comp Neurol. 1917; 25:565-582
Kanelos and McDeavitt. Neural Transplantation: Potential Role in Traumatic Brain Injury. J Head Trauma Rehabil 1998; 13:1-9
Le Gros Clark WE. Neuronal differentiation.. J Neurol Psychiatr 1940; 3:263-272
Lindvall O et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson’s disease. Science 1990; 247: 574
Thompson WG. Sucessful brain grafting. NY Med J. 1890; 51:107
Borlongan CV, Tajima Y, Trojanowski JQ, Lee VMY, Sanberg PR. Transplantation of cryopreserved human embryonal carcinoma-derived neurons (nt2n cells) promotes functional recovery in ischemic rats. Exp Neurol. 149:310-321, 1998.
Deacon T, Schumacher J, Dinsmore J et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson’s Disease. Nature Med. 3(3):350-353, 1997.
Edge ASB, Gosse ME, Dinsmore J. Xenogeneic cell therapy: current progress and future developments in porcine cell transplantation. Cell Transplant. 7(6):525-539, 1998.
Ellias SA, Palmer EP, Kott HS, Schumacher J, Isacson O, Deacon T, Dinsmore J, Fink JS, Thomas C. Fetal porcine ventral mesencephalic transplantation for parkinson’s disease: preliminary results. Move. Disorders. 12(5):839-840, 1997.
Freeman TB, Olanow CW, Hauser RA, Nauert GM, Smith DA, Borlongan CV, Sanberg PR, Holt DA, Kordower JH, Vingerhoets FJG, Snow BJ, Calne D, and Gauger LL. Bilateral fetal nigral transplantation into the postcommissural putamen in parkinson’s disease. Ann. Neurol. 38(3): 379-388, Sept 1995.
Garcia AR, Eacon TW, Dinsmore J, Isacson O. Extensive aconal and glial fiber growth from fetal porcine cortical xenografts n the adult rat cortex. Cell Transplant. 4(5):55515-527, 1995.
Hauser RA, Freeman TB, Snow BJ, Nauert M, Gauger L, Kordower JH, Olanow W. Long-term evaluation of bilateral fetal nigral transplantation in parkinson disease. Arch Neurol. 56:179-187, Feb 1999.
Olanow CW, Freeman TB, Kordower JH. Neural transplantation as a therapy for parkinson’s disease. In: Obeso JA, Delong MR, Ohye C, and Marsden CD (eds). Advances in Neurology: Volume 74: The Basal Ganglia and New Surgical Approaches for Parkinson’s Disease. Lippincott-Raven Publishers: Philadelphia, PA, 1997.
Ostergaard K, Holm IE, Zimmer J. Tyrosine hydroxylase and acetylcholinesterase in the domestic pig mesencephalon: an immunocytochemical study. J Comp Neurol. 322:149, 1992.
Pakzaban P and Isacson O. Neural xenotransplantation : reconstruction of neuronal circuitry across species barriers. Neurosci. 62(4):989-1001, 1994.
Palfi S, Nguyen JP, Brugieres P, LeGuerinel C, Hantraye P, Remy P, Rosraing S, Defer GL, Cesaro P, Keravel Y, Pechanski M. MRI-Stereotactical approach for neural grafting in basal ganglia disorders. Exp. Neurol. 150:272-281, 1998.
Peschanski M, Defer G, Nguyen JP, Ricolfi F, Monfort JC, Remy P, Geny C, Samson Y, Hantraye P, Jeny R, Gatson A, Keravel Y, Degos JD, Cesaro P. Bilateral motor improvement and alteration of L-dopa effect in two patients with parkinson’s disease following intrastriatal transplantation of fetal ventral mesencephalon. Brain 117:487-499, 1994.
Sherwood L. Human Physiology: From cells to Systems (3rd ed), Wadsworth Publishing Co, Belmont CA, 1997. pp 124.
Wenning GK, Oden P, Morrish P, Rehncrona S, Widner H, Brudin P, Rothwell JC, Brown R, Gustavii B, Hagell P, Jahanshahi M, Sawle Gm Bjorklund A, Brooks DJ, Marsden CD, Quinn NP, Lindvall O. Short and long-term survival and function of unilateral intrastriatal dopaminergic grafts in parkinson’s disease. Ann. Neurol. 42:95-107, July 1997.
Widner H and the Neural Tissue Transplant Team (NETTLU). Review of allo- and xenogeneic neural grafts in neurodegenerative disorders. Transplant. Proc. 31:936-938, 1999.
Borlongan, CV, Stahl, CE, Cameron, DF, Saporta, S, Freeman, TB, Cahill, DW, and PR Sanberg. CNS immunological modulation of neural graft rejection and survival. Neurological Research 18:297-304 (1996).
Dunnett, SB and A Bjorklund. Neural Transplantation: A Practical Approach. IRL Press: Oxford 1992.
Fink, J. Stephen. Transplantation in Parkinson’s Disease. Artificial Organs 21(11):1199-1202.(1997).
Jones, D. Gareth and Corolyn M Redpath. Regeneration in the central nervous system: pharmacological intervention, xenotransplantation, and stem cell transplantiation. Clinical Anatomy 11:263-270 (1998).
O’Leary, MT, Bujdoso, R and WF Blakemore. Rejection of Wild-type and Genetically engineered major histocompatiblility complex-deficient glial cell xenografts in the central nervous system results in bystander demyelination and wallerian degeneration. Neuroscience 85(1):269-280 (1998).
Pakzaban, P, Deacon, TW, Burns, LH, Dinsmore, J, and O Isacson. A novel mode of immunoprotection of neural xenotransplants: masking of donor major histocompatibility complex class I enhances transplant survival in the central nervous system. Neuroscience 65(4):983-996 (1995).
Sloan, DJ, Wood, MJ, and HM Charlton. TINS 14(8):341-347 (1991).
Burd L, Gregory JM, Kerbeshian J: The brain-mind quiddity: ethical issues in the use of human brain tissue for therapeutic and scientific purposes, Journal of Medical Ethics 1998; 24: 118-122.
Dunstan GR: The ethics of organ donation, British Medical Bulletin 1997; 53(4): 921-939.
Jones DG, Harris RJ: Neural Transplantation, The New Zealand Medical Journal 1996; 109: 369-371
Turner DA, Kearney WK: Scientific and Ethical Concerns in Neural Fetal Tissue Transplantation, Neurosurgery 1993; 33 :1031-1035.
Xenotransplantation Science, Ethics, and Public Policy; Committee on Xenograft Transplantation: Ethical Issues and Public Policy. Washington D.C.; National Academy Press, 1996.
Xenotransplantation: Anglo-American Update; Department of bioethics and the ethics committee: The Cleveland Clinic Foundation; http://www.ccf.org/ed/bioethic/biocon10.htm
Response to the Advisory Group on the Ethics of Xenotransplantation, made to the Department of Health: Institute of Biology; http://www.primex.co.uk/iob/d13.html
Federal guidelines needed to ensure safety
in animal-to-human organ transplants; Institute of Medicine, http://www2.nas.edu/whatsnew/24f6.html